Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
4.050
+0.190 (4.92%)
At close: Dec 20, 2024, 4:00 PM
4.020
-0.030 (-0.74%)
After-hours: Dec 20, 2024, 6:47 PM EST
Metagenomi Revenue
Metagenomi had revenue of $11.51M in the quarter ending September 30, 2024, a decrease of -6.87%. This brings the company's revenue in the last twelve months to $55.08M, up 45.13% year-over-year. In the year 2023, Metagenomi had annual revenue of $44.76M with 160.21% growth.
Revenue (ttm)
$55.08M
Revenue Growth
+45.13%
P/S Ratio
1.81
Revenue / Employee
$233,390
Employees
236
Market Cap
151.57M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 44.76M | 27.56M | 160.21% |
Dec 31, 2022 | 17.20M | 16.96M | 6,978.19% |
Dec 31, 2021 | 243.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMGX News
- 10 days ago - Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV” - GlobeNewsWire
- 12 days ago - Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting - GlobeNewsWire
- 26 days ago - Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
- 26 days ago - FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi - Business Wire
- 27 days ago - The Schall Law Firm Invites Investor Participation In A Securities Fraud Case Against Metagenomi Inc - Accesswire
- 27 days ago - MGX Deadline: Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business Wire
- 4 weeks ago - Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Affected Stockholders Are Urged To Assist The Schall Law Firm - Accesswire
- 4 weeks ago - MGX Deadline: MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Lawsuit - PRNewsWire